California State Teachers Retirement System acquired a new position in shares of Pulse Biosciences, Inc (NASDAQ:PLSE) in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 16,100 shares of the company’s stock, valued at approximately $556,000. California State Teachers Retirement System owned about 0.11% of Pulse Biosciences at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of the stock. OxFORD Asset Management LLP acquired a new position in Pulse Biosciences in the 2nd quarter valued at $310,000. New York State Common Retirement Fund acquired a new position in Pulse Biosciences in the 2nd quarter valued at $338,000. Rhumbline Advisers acquired a new position in Pulse Biosciences in the 2nd quarter valued at $325,000. Bank of New York Mellon Corp acquired a new position in Pulse Biosciences in the 2nd quarter valued at $897,000. Finally, Wells Fargo & Company MN raised its holdings in Pulse Biosciences by 21,473.2% in the 2nd quarter. Wells Fargo & Company MN now owns 53,933 shares of the company’s stock valued at $1,862,000 after acquiring an additional 53,683 shares during the last quarter. Hedge funds and other institutional investors own 9.35% of the company’s stock.
In related news, Director Mitchell E. Levinson acquired 3,835 shares of the stock in a transaction dated Thursday, September 14th. The stock was bought at an average cost of $12.30 per share, with a total value of $47,170.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Maky Zanganeh acquired 29,775 shares of the stock in a transaction dated Monday, September 18th. The shares were bought at an average cost of $13.36 per share, with a total value of $397,794.00. Following the completion of the purchase, the director now directly owns 315,725 shares in the company, valued at $4,218,086. The disclosure for this purchase can be found here. Insiders acquired a total of 2,466,429 shares of company stock valued at $36,893,301 over the last quarter. 6.70% of the stock is currently owned by insiders.
Pulse Biosciences (NASDAQ:PLSE) last issued its quarterly earnings results on Tuesday, November 7th. The company reported ($0.52) earnings per share for the quarter.
COPYRIGHT VIOLATION NOTICE: “16,100 Shares in Pulse Biosciences, Inc (PLSE) Acquired by California State Teachers Retirement System” was originally published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this story on another publication, it was illegally copied and republished in violation of US & international trademark & copyright law. The original version of this story can be read at https://www.chaffeybreeze.com/2017/12/06/16100-shares-in-pulse-biosciences-inc-plse-acquired-by-california-state-teachers-retirement-system.html.
Pulse Biosciences Company Profile
Pulse Biosciences, Inc, formerly Electroblate, Inc, is a development-stage medical device company using a platform technology called Nano-Pulse Electro-Signaling (NPES). NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue.
Want to see what other hedge funds are holding PLSE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pulse Biosciences, Inc (NASDAQ:PLSE).
Receive News & Ratings for Pulse Biosciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences Inc and related companies with MarketBeat.com's FREE daily email newsletter.